Lachin JM - Search Results

1

Termination of a clinical trial with no treatment group difference: the Lupus Nephritis Collaborative Study.

Lachin JM, Lan SP. Lachin JM, et al. Control Clin Trials. 1992 Feb;13(1):62-79. doi: 10.1016/0197-2456(92)90030-4. Control Clin Trials. 1992. PMID: 1315665 Clinical Trial.

2

A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.

Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM. Lewis EJ, et al. Among authors: lachin jm. N Engl J Med. 1992 May 21;326(21):1373-9. doi: 10.1056/NEJM199205213262101. N Engl J Med. 1992. PMID: 1569973 Free article. Clinical Trial.

3

Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide.

Levey AS, Lan SP, Corwin HL, Kasinath BS, Lachin J, Neilson EG, Hunsicker LG, Lewis EJ. Levey AS, et al. Ann Intern Med. 1992 Jan 15;116(2):114-23. doi: 10.7326/0003-4819-116-2-114. Ann Intern Med. 1992. PMID: 1727614 Clinical Trial.

4

Statistical properties of randomization in clinical trials.

Lachin JM. Lachin JM. Control Clin Trials. 1988 Dec;9(4):289-311. doi: 10.1016/0197-2456(88)90045-1. Control Clin Trials. 1988. PMID: 3060315 Review.

5

Properties of simple randomization in clinical trials.

Lachin JM. Lachin JM. Control Clin Trials. 1988 Dec;9(4):312-26. doi: 10.1016/0197-2456(88)90046-3. Control Clin Trials. 1988. PMID: 3203523

6

Randomization in clinical trials: conclusions and recommendations.

Lachin JM, Matts JP, Wei LJ. Lachin JM, et al. Control Clin Trials. 1988 Dec;9(4):365-74. doi: 10.1016/0197-2456(88)90049-9. Control Clin Trials. 1988. PMID: 3203526 Free article.

7

In memoriam: Max Halperin (1917-1988).

Lachin J, Gordon T, Greenhouse S, Lan KK, Wittes J. Lachin J, et al. Control Clin Trials. 1988 Jun;9(2):170-2. doi: 10.1016/0197-2456(88)90041-4. Control Clin Trials. 1988. PMID: 3293910 Clinical Trial. No abstract available.

8

Low-dose chenodiol to prevent gallstone recurrence after dissolution therapy.

Marks JW, Lan SP, Baum RA, Habig RL, Hanson RF, Hersh T, Hightower NC Jr, Hofmann AF, Lachin JM, Lasser EC, et al. Marks JW, et al. Among authors: lachin jm. Ann Intern Med. 1984 Mar;100(3):376-81. doi: 10.7326/0003-4819-100-3-376. Ann Intern Med. 1984. PMID: 6364909 Clinical Trial.

9

The effects of chenodiol on biliary lipids and their association with gallstone dissolution in the National Cooperative Gallstone Study (NCGS).

Grundy SM, Lan SP, Lachin J. Grundy SM, et al. J Clin Invest. 1984 Apr;73(4):1156-66. doi: 10.1172/JCI111301. J Clin Invest. 1984. PMID: 6368591 Free PMC article. Clinical Trial.

10

Ultrastructural evidence of intrahepatic cholestasis before and after chenodeoxycholic acid therapy in patients with cholelithiasis: the national cooperative gallstone study.

Phillips MJ, Fisher RL, Anderson DW, Lan SP, Lachin JM, Boyer JL. Phillips MJ, et al. Among authors: lachin jm. Hepatology. 1983 Mar-Apr;3(2):209-20. Hepatology. 1983. PMID: 6832711

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters